Skip to main content
Fig. 3 | Diabetology & Metabolic Syndrome

Fig. 3

From: Gradual increasing dyslipidemia in treatment-naive male patients with human immunodeficiency virus and treated with tenofovir plus lamivudine plus efavirenz for 3 years

Fig. 3

Long-term dynamic changes in lipid metabolic parameters over 144 weeks after initial ART with TDF plus 3TC plus EFV in treatment-naive patients with HIV (n = 61). A TC level. B LDL-c level. C HDL-c level. D TG level. ART, active antiretroviral therapy. TDF, Tenofovir. 3TC, Lamivudine. EFV, Efavirenz. TC, total cholesterol. LDL-c, low-density lipoprotein cholesterol. HDL-c, high-density lipoprotein cholesterol. TG, triglyceride. ANOVA was used to compare lipid metabolism parameters from baseline to 144 weeks, and a paired t-test was used to compare lipid metabolism parameters between baseline and some follow-up time points. Comparison between different time points and compared with baseline, *P < 0.05, ** P < 0.01, ***P < 0.001, ****P < 0.0001

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us